Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 51.63m |
Free float | 51.15m |
P/E (TTM) | 24.62 |
Market cap | 10.64bn USD |
EPS (TTM) | 8.37 USD |
Data delayed at least 15 minutes.
More ▼
Press releases
- Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research
- Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience
- Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
- Charles River Laboratories Announces Second-Quarter 2024 Results
- Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development
- Charles River Laboratories and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug Discovery
- Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call
- Charles River to Perform Plasmid Manufacturing for AAVantgarde
- Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus
More ▼